Lipoxin a4 analogs attenuate induction of intestinal epithelial proinflammatory gene expression and reduce the severity of dextran sodium sulfate-induced colitis. - Wikidata - awgldk - TriplyDB

Lipoxin a4 analogs attenuate induction of intestinal epithelial proinflammatory gene expression and reduce the severity of dextran sodium sulfate-induced colitis.

Lipoxin a4 analogs attenuate induction of intestinal epithelial proinflammatory gene expression and reduce the severity of dextran sodium sulfate-induced colitis.

http://www.wikidata.org/entity/Q40733883

about

Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1 Eicosanoid pathway in colorectal cancer: Recent updates Lipidomic profiling of bioactive lipids by mass spectrometry during microbial infections The role of pro-resolution lipid mediators in infectious disease The Dual Role of Neutrophils in Inflammatory Bowel Diseases Lipoxins and novel 15-epi-lipoxin analogs display potent anti-inflammatory actions after oral administration Specialized pro-resolving mediators: endogenous regulators of infection and inflammation Roles of lipoxin A4 receptor activation and anti-interleukin-1β antibody on the toll-like receptor 2/mycloid differentiation factor 88/nuclear factor-κB pathway in airway inflammation induced by ovalbumin Up-regulation of Annexin-A1 and lipoxin A(4) in individuals with ulcerative colitis may promote mucosal homeostasis Annexin A1 regulates intestinal mucosal injury, inflammation, and repair Inflammatory bowel disease Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators Lipoxin A4 inhibits immune cell binding to salivary epithelium and vascular endothelium.Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus.Systems approach with inflammatory exudates uncovers novel anti-inflammatory and pro-resolving mediators.Temporal and spatial analysis of clinical and molecular parameters in dextran sodium sulfate induced colitis.Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection.Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease.Omega-6 docosapentaenoic acid-derived resolvins and 17-hydroxydocosahexaenoic acid modulate macrophage function and alleviate experimental colitis.Novel anti-inflammatory--pro-resolving mediators and their receptors Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis A novel rat lipoxin A4 receptor that is conserved in structure and function.Lipoxin A(4) regulates bronchial epithelial cell responses to acid injury.Kinetics of gene expression in murine cutaneous graft-versus-host disease.Aspirin-triggered lipoxin A4 attenuates LPS-induced pro-inflammatory responses by inhibiting activation of NF-κB and MAPKs in BV-2 microglial cells 15-epi-lipoxin A4 reduces the mortality of prematurely born pups in a mouse model of infection-induced preterm birth.Arachidonic acid and docosahexaenoic acid suppress osteoclast formation and activity in human CD14+ monocytes, in vitro Omega-3 fatty acids and inflammatory processes In Vivo Availability of Pro-Resolving Lipid Mediators in Oxazolone Induced Dermal Inflammation in the Mouse.Parasite-induced lipoxin A4 is an endogenous regulator of IL-12 production and immunopathology in Toxoplasma gondii infection Aspirin triggered-lipoxin A4 reduces the adhesion of human polymorphonuclear neutrophils to endothelial cells initiated by preeclamptic plasma.Anti-inflammatory and proresolving lipid mediators.Matrix metalloproteinase-9-mediated tissue injury overrides the protective effect of matrix metalloproteinase-2 during colitis.Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases.Acetylsalicylic Acid reduces the severity of dextran sodium sulfate-induced colitis and increases the formation of anti-inflammatory lipid mediators.The immune-stimulating peptide WKYMVm has therapeutic effects against ulcerative colitis.Inflammatory bowel disease: mechanisms, redox considerations, and therapeutic targets.The sunburn response in human skin is characterized by sequential eicosanoid profiles that may mediate its early and late phases A beta-oxidation-resistant lipoxin A4 analog treats hapten-induced colitis by attenuating inflammation and immune dysfunction.

P2860

Q24297600-0F311C53-AAF0-43BE-B5AA-41629E32203F Q26778011-CAF14CD6-4E29-470D-8516-820DDE3D50E8 Q26825122-61210182-A7C6-429A-92CE-844A960C0812 Q26863204-467599BF-6F6D-4DF4-84AB-0148A1E7474F Q28080144-C3F9A001-0147-4733-A547-E3BBAE84D277 Q28210465-B740FE21-9D49-4D3D-9DE1-DE5088889D56 Q28271331-A8ADB638-9DBD-4BBA-8AA9-7F390ECB81ED Q28394575-1CDF09AB-D75B-45F4-9583-BBA63970FDE6 Q28480492-68BC983A-ABEE-4517-9210-A4FF14B99BA4 Q28594440-EF22B5CA-2B32-4B9F-A76B-C272CDF3221D Q29615500-A525589F-7849-4AE8-985B-7EAC0F28BFCB Q29615694-B3BD8815-E227-47F0-80AE-F343F7BF5DF8 Q30513559-C4E497EE-F47E-4C4A-A407-90102EBED97E Q31134484-D336F0A2-D36E-48A7-8298-F0DB075351B8 Q33384350-804AF296-83D6-44DB-AA50-320EECDAA66D Q33475620-4AE2AE6E-CA7B-4CB4-BA87-5E67248AD61B Q33531335-F91CB96F-CC40-4099-82A0-34F8343FCF7B Q33785525-8819A7E9-A021-4E24-B6AE-29FEC59CAF03 Q34233126-90601A68-C6B9-4CD8-B9B6-2CAA8428CCC1 Q34276710-03336710-3E3C-4B85-AD41-2A2B56EBF161 Q34982051-5063038B-4AA4-4796-98D8-9E17DBDD2A1E Q34983954-BE6379DE-7E52-4431-A697-D747833C50C1 Q35045249-0FA42C32-31F7-490A-944F-6ACE5307BD2A Q35088140-B07D8764-FC56-459B-A6AF-A6B480AA9195 Q35098314-1BBEA193-B270-497E-A12F-21F2FEC04AFB Q35184153-A09D4EBF-FF54-49AB-9C55-47B462618961 Q35236981-437F8BC5-8C62-4EF6-8047-AF401BF4F839 Q35388976-BF2A2724-E715-46A5-9C3A-573B4A549718 Q35670928-C3525477-E7F8-42DD-BABC-4FE6097ABC16 Q35849963-0D3A1EF5-C042-4752-B853-DDD89D7BD100 Q36371418-ADBEDFCF-7DFE-4C81-B875-1B0C72B25BB2 Q36390428-62351629-E8B6-447B-AB92-65DB17CEE042 Q37071968-9FF70CA8-A696-43CA-B30C-F19F0B0E6EC8 Q37100247-C395608F-862D-4AD9-9B9E-9C35D9C646F6 Q37173857-AE2D24D0-C164-44DE-94F6-E048E43CFAA4 Q37191009-B3F73567-1CF5-4D1C-BC6F-7A8DB8E49633 Q37212182-909FD5A4-99B0-43A5-8170-301F9A804FC9 Q37258771-DC95A2F3-54A7-42D1-9CEC-BDD01199EB1D Q37467875-64347B6F-ACB5-4C74-8254-4D0CBD7CD6B6 Q37591768-76BA3E1B-7C95-4858-9215-F77E73E2540B

P2860

Lipoxin a4 analogs attenuate induction of intestinal epithelial proinflammatory gene expression and reduce the severity of dextran sodium sulfate-induced colitis.

http://www.wikidata.org/entity/Q40733883

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh

2002年學術文章

@zh-hant

name

Lipoxin a4 analogs attenuate i ...... odium sulfate-induced colitis.

@en

type

label

Lipoxin a4 analogs attenuate i ...... odium sulfate-induced colitis.

@en

prefLabel

Lipoxin a4 analogs attenuate i ...... odium sulfate-induced colitis.

@en

P1433

Q40733883-98C6BE73-938A-42B0-9FFB-EC81F97A9EA1

P1476

Q40733883-4D6FB3D7-01CD-4303-BBBE-A0915E3979DE

P2093

Q40733883-605A489C-600D-4956-8F7D-92B7DF511D42

Q40733883-8B76124E-5164-4E0E-A36B-3EA61520EF98

Q40733883-8F3E86E8-4B41-45E7-B7E2-3B8C0DBE5A51

Q40733883-A1EF7AE3-E48B-4C86-95A4-96814D1E99AC

Q40733883-A75B972F-38C2-4257-BBCE-38F5A07B16E8

Q40733883-B631F539-9088-47E8-80F9-908003B43BF3

Q40733883-C861BFE3-8705-4681-8778-E4594092BCF5

Q40733883-E4FBBE4F-5E51-4BC1-B25A-1A43A7B62B6C

Q40733883-F80482F7-C9F4-45BF-9C6B-E3F9F4F1ACB6

P304

Q40733883-7174DF24-BA5B-4E85-9B98-A8C43B8F754E

P31

Q40733883-72075910-9353-4928-BEC9-6C9C76D3E537

P356

Q40733883-D6B4933F-BDA2-47E5-8267-69411B65FF60

P407

Q40733883-4CAC6C8B-6F9F-4426-8A2C-AFBBBCB3ABC9

P433

Q40733883-D76EB3F9-C08A-4837-9F21-D0500F83ADCF

P478

Q40733883-15082372-25EB-483D-80D7-DCBA0B342EEF

P577

Q40733883-29F73F2E-BEDA-41FB-B100-6800CC597564

P5875

Q40733883-DC43683F-4124-48A5-B3EF-6A2EE9898C56

P698

Q40733883-51D80515-9415-4009-A7D6-4CB896220852

P356

JIMMUNOL.168.10.5260

P1433

Journal of Immunology

P1476

Lipoxin a4 analogs attenuate i ...... odium sulfate-induced colitis.

@en

P2093

Andrew N Young

http://www.w3.org/2001/XMLSchema#string

Andrew S Neish

http://www.w3.org/2001/XMLSchema#string

Andrew T Gewirtz

http://www.w3.org/2001/XMLSchema#string

Ifor R Williams

http://www.w3.org/2001/XMLSchema#string

James L Madara

http://www.w3.org/2001/XMLSchema#string

John F Parkinson

http://www.w3.org/2001/XMLSchema#string

Lauren S Collier-Hyams

http://www.w3.org/2001/XMLSchema#string

Torsten Kucharzik

http://www.w3.org/2001/XMLSchema#string

William J Guilford

http://www.w3.org/2001/XMLSchema#string

P304

5260-5267

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.168.10.5260

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

168

http://www.w3.org/2001/XMLSchema#string

P577

2002-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11375131

http://www.w3.org/2001/XMLSchema#string

P698

11994483

http://www.w3.org/2001/XMLSchema#string